Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Prognostic Factors and Models predicting Unfavorable Outcome After lumbar Discectomy: A Systematic Review.

World neurosurgery·2026
Same author

Nucleoplasty for cervical radicular pain due to disc herniation.

The Cochrane database of systematic reviews·2025
Same author

Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice.

Research and practice in thrombosis and haemostasis·2024
Same author

Smartphone-based thermography to determine shunt patency in patients with hydrocephalus.

Acta neurologica Belgica·2023
Same author

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients.

European journal of clinical pharmacology·2021

Related Experiment Video

Updated: Jul 8, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

Coagulation disorders after traumatic brain injury.

B S Harhangi1, E J O Kompanje, F W G Leebeek

  • 1Department of Neurosurgery, Erasmus MC, Rotterdam, The Netherlands. b.s.harhangi@erasmusmc.nl

Acta Neurochirurgica
|January 2, 2008
PubMed
Summary

Coagulopathy, or blood clotting disorders, affect over 30% of traumatic brain injury (TBI) patients. Early assessment of blood coagulation is crucial as it independently predicts poor outcomes and mortality in TBI.

More Related Videos

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
06:50

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

Published on: June 10, 2020

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury
04:03

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

Published on: February 21, 2025

Related Experiment Videos

Last Updated: Jul 8, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
04:56

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)

Published on: August 4, 2023

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
06:50

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

Published on: June 10, 2020

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury
04:03

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

Published on: February 21, 2025

Area of Science:

  • Neuroscience
  • Hematology
  • Trauma Surgery

Background:

  • Recent advances highlight tissue factor's role in coagulation.
  • Brain tissue factor can trigger local and systemic coagulation disturbances after injury.
  • Traumatic brain injury (TBI) may initiate significant coagulation dysregulation.

Purpose of the Study:

  • To review current knowledge on coagulation disorders post-TBI.
  • Investigate pathophysiology, incidence, nature, prognosis, and treatment.
  • Determine the association between coagulopathy and TBI outcomes.

Main Methods:

  • Comprehensive MEDLINE search (1966-2007) for head trauma and coagulopathy.
  • Inclusion of 441 eligible English-language studies.
  • Meta-analysis of 34 studies to calculate coagulopathy frequency and outcome association.

Main Results:

  • Coagulopathy prevalence in TBI patients was 32.7%.
  • Coagulopathy significantly increased mortality risk (OR 9.0).
  • Coagulopathy strongly associated with unfavorable outcomes (OR 36.3).

Conclusions:

  • Coagulopathy is an independent risk factor for prognosis in TBI.
  • Routine coagulation status assessment is recommended for all TBI patients.
  • Further clinical trials are needed to evaluate early coagulopathy treatment benefits.